**Core Concept**
Metformin is a biguanide antidiabetic medication that can cause lactic acidosis, a potentially life-threatening condition, especially in patients with renal impairment. This is because metformin is primarily excreted by the kidneys, and in cases of acute kidney injury or chronic kidney disease, the risk of lactic acidosis increases.

**Why the Correct Answer is Right**
Metformin should be stopped in a patient with diabetes and elevated serum creatinine levels (indicating impaired renal function) to prevent the accumulation of the drug and the associated risk of lactic acidosis. The kidneys play a crucial role in the excretion of metformin, and in the case of renal impairment, the drug can accumulate, leading to increased lactate production and potentially fatal outcomes. In contrast, insulin, metoprolol, and linagliptin do not require immediate discontinuation in patients with renal impairment.

**Why Each Wrong Option is Incorrect**
**Option B:** Insulin is not associated with an increased risk of lactic acidosis and is not contraindicated in patients with renal impairment. In fact, insulin therapy is often continued in patients with diabetes and renal disease.
**Option C:** Metoprolol, a beta-blocker, is not directly related to the risk of lactic acidosis or renal impairment. Its use in patients with hypertension and diabetes is not contraindicated.
**Option D:** Linagliptin, a DPP-4 inhibitor, is primarily excreted by the liver and does not require dose adjustment in patients with renal impairment. It is not associated with an increased risk of lactic acidosis.

**Clinical Pearl / High-Yield Fact**
In patients with diabetes and renal impairment, it is essential to carefully evaluate the medication regimen and adjust or discontinue medications that may increase the risk of lactic acidosis or exacerbate renal disease, such as metformin.

**✓ Correct Answer: A. Metformin**